We utilized a 5 Gy, sub-ablative dose of radiotherapy to induce TGFβ signaling in the TME (52) while still allowing for viable tumor and immune cells to persist, thus permitting the analysis of the impact of radiotherapy on Ewing sarcoma immunobiology. The gene discussed is TGFB1; the disease is neoplasm.